| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dca5aa39e60833794091ceff0771c340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate |
2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_301b3b27f5bdf0581be6457f80789e6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3e2a999a96a0f4e4b844ff859370752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a08f52243f2ab0638a238cb7403c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d00661221b16d47a9cb06ea55be18048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_277ee4e2e76c3fc2ded83f97343fd29c |
| publicationDate |
2010-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010027832-A1 |
| titleOfInvention |
Method for reducing scarring during wound healing using antisense compounds directed to ctgf |
| abstract |
This invention provides a method for reducing hypertropic scarring resulting from dermal wound healing in a subject in need which comprises administering to the subject an antisense oligonucleotide which inhibits expression of connective tissue growth factor (CTGF) in an amount effective to inhibit expression of CTGF and thereby reduce hypertrophic scarring. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10138485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9303259-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10184124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11396654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9095504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10900039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9115356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10913948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8664189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963702-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815485-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2465902-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10662430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802839-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11584933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9340786-B2 |
| priorityDate |
2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |